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Introduction
Accurate surveillance definitions are necessary to evalu-
ate the impact of interventions to prevent central line–
associated bloodstream infections (CLABSIs). Although,
the National Healthcare Safety Network (NHSN) defini-
tion for CLABSI has been applied extensively in intensive
care units, few studies have examined its performance
among bone marrow transplant (BMT) recipients. As
those patients have inherent risks for bloodstream infec-
tions associated with mucosal barrier injury, more specific
definitions are necessary for catheter-related bloodstream
infection (CRBSI) in order to determine the impact of
improvement projects to decrease these device-associated
infections (DAIs).
Objectives
To determine the impact of a care bundle in the CRBSI
rates in a BMT population using a specific definition.
Methods
Since Feb’10, a care bundle for insertion and maintenance
of central venous catheter was implemented across our
institution. While CLABSI was defined using NHSN cri-
teria, a definitive diagnosis of CRBSI required that the
same organism grew from at least 1 percutaneous blood
culture and from a semiquantitative culture of the catheter
tip, or that 2 blood samples drawn, one from a catheter
hub and the other from a peripheral vein, showed differen-
tial time to positivity (DTP) ≥ 2 hours. Episodes with a
DTP < 2 hours were categorized as catheter-non related
bloodstream infection (CNRBSI). The impact of care
bundle was estimated comparing 2012 vs 2009, CRBSI and
CNRBSI incidence density rates.
Results
While the CRBSI rate showed a reduction from 8.94 per
1,000 central line–days to 2.93 per 1,000 central line–
days (difference 6.01; CI 95%>1.59 to 13.61, p=0.07),
CNRBSI showed a marginal reduction from 5.96 per
1,000 central line–days to 4.69 per 1,000 central line–
days (difference 1.28; CI 95%>5.41 to 7.96, p=0.68).
While in CNRBSI intestinal organisms predominated
(79%, 23/29), the most common organisms isolated in
CRBSI was coagulase-negative Staphylococcus (78%,
14/18).
Conclusion
Using DTP as part of CRBSI definition allowed us to
accurately assess the impact of a care bundle in the
reduction of these DAIs.
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